Bio

Andrew Bergman (Menlo Park) joined KKR in 2014 and is a member of the Health Care industry team. He is currently involved with the firm's investments in Arbor Pharmaceuticals, BridgeBio Pharma, and Covenant Surgical Partners, and was previously involved with KKR's investments in Ajax Health, Hanger, Lake Region Medical, and Spirox. Mr. Bergman holds a B.A., cum laude, in Economics-Accounting and Psychology and a M.A. in Finance from Claremont McKenna College.